Cart
sales@molnova.com
Home -
Products -
Antibody Drug Conjugates (ADC) -
ADCs Linker/Click Chemistry -
DBCO-PEG3-NHS ester
DBCO-PEG3-NHS ester
CAS No. 2163772-16-3
DBCO-PEG3-NHS ester( —— )
Catalog No. M33546 CAS No. 2163772-16-3
DBCO-PEG3-NHS ester is a degradable ADC linker that can be used to synthesize antibody-coupled active molecules.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 271 | Get Quote |
|
| 5MG | 426 | Get Quote |
|
| 10MG | 625 | Get Quote |
|
| 25MG | 908 | Get Quote |
|
| 50MG | 1279 | Get Quote |
|
| 100MG | 1692 | Get Quote |
|
| 500MG | 3411 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDBCO-PEG3-NHS ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionDBCO-PEG3-NHS ester is a degradable ADC linker that can be used to synthesize antibody-coupled active molecules.
-
DescriptionDBCO-PEG3-NHS ester is a degradable ADC linker that can be used to synthesize antibody-coupled active molecules.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAntibody Drug Conjugates (ADC)
-
TargetADCs Linker/Click Chemistry
-
RecptorADC Linker
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2163772-16-3
-
Formula Weight605.64
-
Molecular FormulaC32H35N3O9
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(ON1C(=O)CCC1=O)CCOCCOCCOCCNC(=O)CCC(=O)N2C=3C=CC=CC3C#CC=4C=CC=CC4C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
DBCO-NHS ester
An amine-reactive NHS ester that provides easy attachment of the reactive moiety to almost any primary or secondary amine group, such as that of protein, peptide, or small molecule amine.
-
Biotin-PEG3-SS-azide
Biotin-PEG3-SS-azide (Biotin-PEG3-amido-SS-amido-azide) is a cleavable ADC linker containing 3-unit PEG and can be used to synthesize antibody-drug conjugates (ADCs).
-
BS3 Crosslinker
BS3 Crosslinker is a non-cleavable linker used in the synthesis of antibody-drug conjugates (ADCs). It connects antibodies with drugs, thereby enhancing the overall efficiency and effectiveness of the resulting ADC.
